INACTIVATION OF NIAID PROGRAM ANNOUNCEMENT PA-01-055 RELEASE DATE: December 2, 2003 NOTICE: NOT-AI-04-009 National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov) PURPOSE The Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID) announces the closure of Program Announcement, PA-01-055, “NEW TECHNOLOGIES FOR HIV AND HIV VACCINE RELATED RESEARCH” that appeared in the NIH Guide on February 22, 2001 at https://grants.nih.gov/grants/guide/pa-files/PA-01-055.html. The final receipt date for applications was September 1, 2003. The PA solicited applications for novel and innovative research in target areas to develop improved technologies for detecting HIV, evaluating immune responses to HIV vaccines, and expanding immune function measurements; and utilizing novel technologies to measure and correlate immune responses that are associated with efficacy of licensed non-HIV vaccines. At this time investigator-initiated research in these areas is still strongly encouraged through R01 applications. INQUIRES Program Officers in the Vaccine Clinical Research Branch are available to offer advice and assistance on anticipated applications. Contact them by calling (301) 496-8379 or through the NIAID/DAIDS website, http://www.niaid.nih.gov/daids/. At any time, potential applicants can obtain a current listing of active NIAID PAs on the NIAID WWW site at URL: http://www3.niaid.nih.gov/about/organization/daids/.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Department of Health
and Human Services
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892